GlobeNewswire: Titan Medical Inc. Contains the last 10 of 199 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T15:31:45ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/20/2849268/0/en/Titan-Announces-Q-A-Session-with-Shareholders.html?f=22&fvtc=4&fvtv=41044Titan Announces Q&A Session with Shareholders2024-03-20T11:30:00Z<![CDATA[TORONTO, Ontario, March 20, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that management will host a webcast Q&A session on March 27, 2024 at 1:00 p.m. ET in connection with the merger agreement entered into by Titan with Conavi Medical Inc. (“Conavi”), which was announced by press release issued on March 18, 2024. Titan will provide prepared remarks followed by a Q&A session. Paul Cataford, Interim President and CEO and Chien Huang, Chief Financial Officer will attend the session on behalf of Titan.]]>https://www.globenewswire.com/news-release/2024/03/18/2847703/0/en/Titan-Announces-Merger-Agreement-with-Conavi.html?f=22&fvtc=4&fvtv=41044Titan Announces Merger Agreement with Conavi2024-03-18T11:30:00Z<![CDATA[- Merger to create publicly-listed, commercial-stage leader in hybrid intravascular imaging - - Merger to create publicly-listed, commercial-stage leader in hybrid intravascular imaging -]]>https://www.globenewswire.com/news-release/2024/03/04/2839436/0/en/Titan-Medical-to-Report-Year-End-2023-Financial-Results-on-March-29-2024.html?f=22&fvtc=4&fvtv=41044Titan Medical to Report Year-End 2023 Financial Results on March 29, 20242024-03-04T12:30:00Z<![CDATA[TORONTO, Ontario, March 04, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today that the Company plans to issue its year-end 2023 financial results after the market closing on March 29, 2024.]]>https://www.globenewswire.com/news-release/2023/12/01/2789570/0/en/Titan-Medical-Announces-Benchmark-Electronics-Inc-Purported-to-Terminate-Agreement.html?f=22&fvtc=4&fvtv=41044Titan Medical Announces Benchmark Electronics, Inc. Purported to Terminate Agreement2023-12-01T22:00:00Z<![CDATA[TORONTO, Ontario, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today that Benchmark Electronics, Inc., the company engaged by Titan under a manufacturing and supply agreement for the manufacture of Titan’s Enos Surgical System, has purported to terminate the agreement. Titan did not receive delivery from Benchmark of manufactured Enos Surgical System units and disputes that Benchmark has grounds for the termination. Titan has rejected Benchmark’s allegation that Titan breached the agreement.]]>https://www.globenewswire.com/news-release/2023/11/02/2772165/0/en/Titan-Medical-Reports-Operating-and-Financial-Results-for-the-Third-Quarter-2023.html?f=22&fvtc=4&fvtv=41044Titan Medical Reports Operating and Financial Results for the Third Quarter 20232023-11-02T11:30:00Z<![CDATA[TORONTO, Ontario, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today financial results for the three and nine months ended September 30, 2023.]]>https://www.globenewswire.com/news-release/2023/10/18/2762621/0/en/Titan-Medical-Announces-Change-in-Auditor.html?f=22&fvtc=4&fvtv=41044Titan Medical Announces Change in Auditor2023-10-18T15:35:14Z<![CDATA[TORONTO, Ontario, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), a medical technology company, announces that it has changed its auditor from BDO Canada LLP (the “Former Auditor”) to MNP LLP (the “Successor Auditor”) effective October 10, 2023. At the request of the Company, the Former Auditor resigned as auditor of the Company on October 10, 2023 and the board of directors of the Company appointed the Successor Auditor as the new auditor until the next annual general meeting of shareholders of the Company.]]>https://www.globenewswire.com/news-release/2023/08/21/2728576/0/en/Titan-Medical-Signs-License-Agreement-with-Auris-Health-Inc.html?f=22&fvtc=4&fvtv=41044Titan Medical Signs License Agreement with Auris Health, Inc.2023-08-21T11:30:00Z<![CDATA[TORONTO, Ontario, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), a medical technology company, announced today that the Company has entered into a licensing agreement (“Agreement”) with Auris Health, Inc., (“Auris Health”), a Johnson & Johnson MedTech company, in respect of certain intellectual property (“IP”) of Titan. Under the Agreement, Titan has granted Auris Health a non-exclusive license to a portion of Titan’s IP.]]>https://www.globenewswire.com/news-release/2023/08/14/2724297/0/en/Titan-Medical-Announces-Appointment-of-New-Independent-Member-to-its-Board-of-Directors.html?f=22&fvtc=4&fvtv=41044Titan Medical Announces Appointment of New Independent Member to its Board of Directors2023-08-14T11:30:00Z<![CDATA[TORONTO, Ontario, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today the appointment of Dr. Daniel O’Brien, MD, MBA, PhD to its Board of Directors. Dr. O’Brien will also serve on the Audit Committee of the Board.]]>https://www.globenewswire.com/news-release/2023/08/10/2723240/0/en/Titan-Medical-Reports-Operating-and-Financial-Results-for-the-Second-Quarter-2023.html?f=22&fvtc=4&fvtv=41044Titan Medical Reports Operating and Financial Results for the Second Quarter 20232023-08-10T21:00:00Z<![CDATA[TORONTO, Ontario, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today financial results for the three and six months ended June 30, 2023.]]>https://www.globenewswire.com/news-release/2023/07/04/2698975/0/en/Titan-Medical-Reports-Voting-Results-From-Annual-General-Meeting-of-Shareholders.html?f=22&fvtc=4&fvtv=41044Titan Medical Reports Voting Results From Annual General Meeting of Shareholders2023-07-04T11:30:00Z<![CDATA[TORONTO, Ontario, July 04, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), a medical technology company, today announced the voting results from the Company’s Annual General Meeting of its shareholders held on June 30, 2023.]]>